GlaxoSmithKline PLC ADR (GSK) stock forecast · P/E 13, $103.31B cap
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
This GSK forecast page states what the cached financials imply — not a price target and not a guarantee. GlaxoSmithKline PLC ADR outlooks on Lician start from reported revenue and the latest filing, then you decide.
No cached income statement for GSK yet, so there is no numeric 2026 base to extend.
Period-over-period revenue change is not in cache for GSK, so this page does not invent a growth rate.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next GSK 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the GSK stock page.
Not investment advice.